Ontology highlight
ABSTRACT:
SUBMITTER: Wagner JR
PROVIDER: S-EPMC4901368 | biostudies-literature | 2016 Jun
REPOSITORIES: biostudies-literature
Wagner Jeffrey R JR Lee Christopher T CT Durrant Jacob D JD Malmstrom Robert D RD Feher Victoria A VA Amaro Rommie E RE
Chemical reviews 20160413 11
Allosteric drug development holds promise for delivering medicines that are more selective and less toxic than those that target orthosteric sites. To date, the discovery of allosteric binding sites and lead compounds has been mostly serendipitous, achieved through high-throughput screening. Over the past decade, structural data has become more readily available for larger protein systems and more membrane protein classes (e.g., GPCRs and ion channels), which are common allosteric drug targets. ...[more]